Takung Art Co. (TKAT) Uplists to the New York Stock Exchange and Rings the Opening Bell March 22, 2017
VIDEO: Opening Bell -and Gong – at the New York Stock Exchange 3/22/17
Ron is an investment professional and executive whose reputation has been established through three decades of success in the formation and successful development of both private and public companies. Mr. Altbach also serves as president of Regeneration Capital Group LLC, a merchant bank focused exclusively on Chinese middle market companies. From 1998 to 2003, Ron founded and served as Chairman and Chief Executive Officer of Cross Media Marketing Corporation, an American Stock Exchange-listed direct marketing company that led the development of modern, technology-driven direct marketing approaches. Mr. Altbach’s background in corporate and development led to his position, from 1995 through 1998, as Vice Chairman of Rosecliff, Inc., a prominent New York-based merchant bank principally engaged in direct investments. Mr. Altbach was a principal in Mediacom Industries which became public through a reverse merger in 1984.
As a founder and president of Market Makers, Jimmy Caplan has served as a consultant to emerging publicly traded companies for more than 30 years. He has helped guide some of those companies through the process of going public, and offers all clients a wide range of business development and investor relations services. These services include but are not limited to: assistance with capital formation, business planning, presentation training for management, introductions to potential strategic investors, preparation and dissemination of corporate news and press releases, and broadening investor interest and analyst coverage. Each client program is individually tailored in response to the client’s needs and aims to improve overall corporate performance and visibility, and maximize the valuation of the company’s common stock. Jimmy has served as a key advisor to management of highly successful public companies such as Labor Ready (now TrueBlue; NYSE:TBI), Inamed Corporation (acquired by Allergan) and Pancretec (acquired by Abbott Labs).
Rick Eisenberg has nearly 30 years experience in providing corporate communications and media relations programs for publicly traded companies. He specializes in placing clients in major business/financial outlets including CNBC, Business Week, The Wall Street Journal, The New York Times, Dow Jones News, Bloomberg Business News, Thomson Reuters, Forbes and Fortune, as well as a wide assortment of the leading online, trade, social and broadcast media. He has worked with over 50 public companies in a variety of industries, including science/healthcare, pharmaceuticals, technology, energy, commodities, consumer products, apparel, entertainment and others. Rick began his career with the nation’s largest PR firm at the time, Burson-Marsteller, then moved on to the biotech specialists, Cameron Associates, and subsequently founded his own IR/PR firm, Eisenberg Communications.